RESUMO
BACKGROUND: The aim of our study was to evaluate the efficacy of electroconvulsive (ECT) and venlafaxine therapy from the patient's point of view. METHODS: We used a retrospective chart review from 22 inpatients who underwent ECT and 22 patients treated with venlafaxine due to resistant unipolar or bipolar depression. We used bilateral ECT in a median of 8 (IQR 7-9.7) sessions and venlafaxine therapy with a median daily dosage of 225 mg (IQR 150-225 mg) for a median of 4 (IQR 4-5) weeks. The main outcome was change in a self-evaluation scale - Short Form of the Beck Depression Inventory (BDI-SF). The response was defined as the decreasing of the BDI-SF score by >or=50%, remission as decreasing of BDI-SF score Assuntos
Antidepressivos de Segunda Geração/uso terapêutico
, Cicloexanóis/uso terapêutico
, Transtorno Depressivo/terapia
, Eletroconvulsoterapia/psicologia
, Satisfação do Paciente
, Adulto
, Transtorno Depressivo/psicologia
, Feminino
, Humanos
, Masculino
, Pessoa de Meia-Idade
, Escalas de Graduação Psiquiátrica
, Estudos Retrospectivos
, Autoavaliação (Psicologia)
, Índice de Gravidade de Doença
, Resultado do Tratamento
, Cloridrato de Venlafaxina